tm logo
DOJOLVI
REGISTERED

on 02 Mar 2022

Last Applicant/ Owned by

ULTRAGENYX PHARMACEUTICAL INC.

60 Leveroni CourtNovato CA 94949

US

Serial Number

1995744 filed on 12th Sep 2019

Registration Number

TMA1121633 registered on 02th Mar 2022

Registration expiry Date

12th Sep 2029

Correspondent Address

1100-150 York StreetToronto

ONTARIO

CA

M5H3S5

DOJOLVI

Trademark usage description

pharmaceuticals for use in treating genetic disorders, autosomal disorders, lysosomal storage disorders, energy deficiency disorders and enzyme disord Read More

Classification Information


Class [005]
Pharmaceuticals for use in treating genetic disorders, autosomal disorders, lysosomal storage disorders, energy deficiency disorders and enzyme disorders; pharmaceuticals for use in treating metabolic disorders, namely, diabetes, bulimia nervosa, anorexia, obesity and hypothyroidism, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, and anemia; pharmaceuticals for use in treating long-chain fatty acid oxidation disorders (LC-FAOD)


Classification kind code

11

Mark Details


Serial Number

1995744

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 22
on 04th Mar 2021
Search Recorded
Submitted for opposition 20
on 04th Mar 2021
Examiner's First Report
Submitted for opposition 223
on 04th Mar 2021
Total Provisional Refusal
Submitted for opposition 256
on 14th Sep 2020
Notification of Possible Opposition Sent
Submitted for opposition 48
on 29th Jan 2020
Agent Changed
Submitted for opposition 257
on 14th Nov 2019
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 13th Nov 2019
Created
Submitted for opposition 31
on 13th Nov 2019
Formalized
Submitted for opposition 30
on 12th Sep 2019
Filed
Submitted for opposition 228
on 12th Sep 2019
International Registration